An update on therapy of primary central nervous system lymphoma Journal Article
| Authors: | Deangelis, L. M.; Iwamoto, F. M. |
| Article Title: | An update on therapy of primary central nervous system lymphoma |
| Abstract: | The most important advance in primary central nervous system (CNS) lymphoma treatment has been the convincing data that high-dose methotrexate-based chemotherapy regimens improve survival compared to historical controls treated with radiotherapy alone. However, the optimal treatment approach is still unclear and therapy can be associated with long-term neurotoxicity. Current research focuses on maximizing survival while minimizing neurologic sequelae. |
| Keywords: | survival rate; mortality; review; multimodality cancer therapy; combined modality therapy; methotrexate; central nervous system tumor; central nervous system neoplasms; lymphoma |
| Journal Title: | Hematology-American Society of Hematology Education Program |
| ISSN: | 1520-4391 |
| Publisher: | American Society of Hematology |
| Date Published: | 2006-01-01 |
| Start Page: | 311 |
| End Page: | 316 |
| Language: | English |
| PUBMED: | 17124077 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 8" - "Export Date: 4 June 2012" - "Source: Scopus" |
